SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001753926-24-001271
Filing Date
2024-07-26
Accepted
2024-07-26 16:05:13
Documents
1
Group Members
3I MANAGEMENT LLCMAIER JOSHUA TARLOW

Document Format Files

Seq Description Document Type Size
1 SC 13G g084353_sc13g.htm SC 13G 87578
  Complete submission text file 0001753926-24-001271.txt   89200
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Subject) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92695 | Film No.: 241146797
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 140 BROADWAY 38TH FLOOR NEW YORK NY 10005
Business Address 874 WALKER ROAD SUITE C DOVER DE 19904 (646) 845-0040
3i, LP (Filed by) CIK: 0001841619 (see all company filings)

IRS No.: 843800874 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G